pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-3057 |
Genomic Coordinates | chr10: 81271597 - 81271687 |
Description | Mus musculus miR-3057 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-3057-5p |
Sequence | 14| AUUGGAGCUGAGAUUCUGCGGGAU |37 |
Evidence | Experimental |
Experiments | Illumina |
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Slc25a46 | ||||||||||||||||||||
Synonyms | 1200007B05Rik, AI325987 | ||||||||||||||||||||
Description | solute carrier family 25, member 46 | ||||||||||||||||||||
Transcript | NM_026165 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Slc25a46 | |||||||||||||||||||||
3'UTR of Slc25a46 (miRNA target sites are highlighted) |
>Slc25a46|NM_026165|3'UTR 1 GATTTAGGTTCTATGATTGGCTGAACCAAAAGATGTTGGATAATTTGCTATGACATTTCAAGTAATAAAAGTAAAAATAC 81 TGCGCGGAAAGAAATAGGCTGGGAATTACCACTGGTGGAAAACCTCATGCTAATTATTCTGACTTTTTATTTTTCTTAAG 161 GCATAGATATATAGATATATAGATATATAATACTGGGTCAAACCTTTCCAAAATTGAAAACTCAATAAAGGTAATACTTT 241 AAATTTAAAATGTAAAGTTACATTTTAGTATAACACTCATGCTGAAGTAAAATTGATCCTGGGGAGAAACAAAAAATGTA 321 TCAAGTATAAAATGAAATTGCAATGACTTGAATCTGTTTTACTGACCTTACTATTTGTTATGTTTGTTTAACTTGGATTC 401 AGGTCACTGTGTTAATTATTAAAGCAGTGGATAGTGCTGGGATTTTACCTTTAAGCAAATAGAGTATGTCACCGTTGAAA 481 AGAACTGGTGATTAGCTTTGGCACTGTGTAAGCAGTGGCTGAAGGGTTTAAATTGTATTTAACCATTTTAATTGCTGTAT 561 ATATTTATTATATGGAGCCATTTGTGTCTGTGTGTACATGTAACTTGGAATTTCCTTCTTCCCTGCCAGTTTTCATAGAC 641 CAGCTTATTGCATCAAATGAAGGTAGACACTTTCTGCTGGAACATCAAGTATAAGACATCAAAATGCCAGAAAATAGCTT 721 TTTTACCTGCATCCTGTCCAGCATTGCAGTGTCAGAAACTTGAAATTTGTCCTTTGCTTGTGATGTTTGGATCATCAGAT 801 GATTTTAGCTACTTTTAAAGAGCCTAACAATCATGGCAGCCATGACCGTTTCCACACTTACGTTAAGGAGCCCCACCTGT 881 CTTTCATTTCTCAAAGAACTTATCTGAGAGGGAACAAAATGAAAGTTCTGGGGATTTGTGCCTCTTGCTCACCATAAATA 961 ATCACTGCAATCTTTCTTTTTTCTTTCCTTTTTTTGTATGTGTGCGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG 1041 TGTATGTAAAGTTTTATTCTCCAAATAAGCTACCCTGAAGATAAAAATGAGACATTCTTGGTACTCTTTATTTAAACTTG 1121 CTTGGATAAGTACTGAATTAAAGTACAAACCTCATAGGAAATTTGCCCTTATGTGTTACGAAGGAGGAGGAGGAGACACT 1201 ATATTTCAACAAATGAAACTTGTTAATCAGCTTAATAAAATGAAGTTGATGTGTTCCCATGGTGGATTAGACTCTGTAAT 1281 AAAGTGATGTATAGTTCACTGGTCACTCATGCAGCAGTTAGCATTTTATTTCTTCATGGCTATGCTCAAGTTTACAAACA 1361 CTGAAGTGCAGTGCCTGCAGGTGTTGCCCAACCTAGAATGCATGCAAACTAACACTGATGTTACATGTTAAATGTTGCAG 1441 AGGGTGTTTGGACTGTGACTGATCAGAGTGGAAGCTTAATATGGTCGTGGAAAAGCATGAAGTAAGGTGTCAGTAGCAGC 1521 TGTCCCTACCAGTCTGTGTCTTTGGAGTAATGCTGTCAACTCTTCAGTTCCTCAAAAGGGAAAATAAATGCTGTTGATCA 1601 CATTCTGTATTTTATGGTTAATCTCTTAACGTGTTTTTCTCTGTGTAAAAATGGGGTTAACATTTTTTACTGACTTTTAG 1681 CTGCTAAATTTTTAGGTGTTTATAGTCACCTTCCTCAGAATTTCATTTTGTAAGTCAAGGTAGTTTCAGAGAAGAAACCA 1761 GAAAATTTTGGTTTCAGAAAATGTTTAGAACAGTCTAAATGGAATCAAATATTTACTGGGTAAATTTTGTGGAATTTTCC 1841 ATGTGCCTGAAGATTAGATATTCAAGGATTATTTATTGACAGATACCATGAATTTAGTAATATAAATTTATTGCATCTGA 1921 AGTCAAAATGCTGCTGCTGAACTAAATACATGATTAGTCTCATTTCCTGTTTCCTTGCAGAAATCCACGCAAATTACCTT 2001 AAAATAAAGATGGAGAGAGTTTTTTTTTCTAACTGCTTTTTTTTTTAAATTTGTTAAAATGTAACCTTTGAAAGTCAAAC 2081 ACATTTTAGTTGGCCAGTGTTTCTCAGTGAATTGATACCTTTTACACTCAGTATGACAAATAGCCCCGTAGATGTGATTC 2161 TGTTAAGTAGAATGCAACAAAGCACTCACTCGCTGATTGTGCAAAAAAACGCTACAGTGCTTTTATTCGAGAATCTCATA 2241 ATCTGAGAAGCAGAAGACGCTGCCTTGACAGCTGTACTGTTGTTGGTCGAGGTCATGGAGGATGTGTGCTGTCTATGTGG 2321 GTGTGGATGCTGTAGAACAGAAAAGACATTTCCAGCTCCTGCAAAAACTACCTATGTGGAGAGCCGTGAACAATCGCCAT 2401 TACAAGATGGCGCTGGCTTCTGCAGTGCCTAACTAGTAAACAAGCAATGTGCACGGGTGCTGGAGTAAATTCGTGCCAAG 2481 TCACTGCCCATCTCGGGGTGTAGCAGTGGGGTGATGAGTGAGCAGCTAATCAGGAGCTGACGCGTCACACGGAGGGGTAT 2561 TTAAGCAGCTCCATTTTCCGGGTTCAGGGTCTTCCTGAGAAGTAAGCAATAAAAAGCTTTGCCGTAGAAGGACCCGGTTG 2641 TCCGAGTGTGTTTTGCTGGCGAGATGTTACAAGGACACACCTAGGTTAAGTGACTTAGAAAACTTATTTAAGGGTTCACA 2721 TCACACTGAAGTTAGAGTACTACTTACTGCTGGCATTTCTGCGTTCTCTTCAAGTATTTGGCATAATACATATCACTTCC 2801 CTGCCCCTGAATAGGTACCATCTTATTTTTATTAATAGAGTACTAGTTTGTATAGCAGAGTAACAATAATCTGTGGTTTG 2881 ACTCTTGTGTCTTGTTATTTTATTTATTTCTAAAATTTATTAAAGGTTTATTTTCTTTATTTTTTAAAATTTTGTCACAG 2961 TACCATTTTAAATGTCTTAGGTAATAAGTTGTAATGTAAAAGGTTTGATAAAATGTTGAATTC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C2C12 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1385342. RNA binding protein: 聽AGO2. Condition:C2C12_GM_Ago2_CLIP-Seq_myoblast
HITS-CLIP data was present in GSM1385343. RNA binding protein: 聽AGO2. Condition:C2C12_DM_Ago2_CLIP-Seq_myotubes
... - Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al., 2014, Cell. |
Article |
- Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al. - Cell, 2014
MicroRNAs are well known to mediate translational repression and mRNA degradation in the cytoplasm. Various microRNAs have also been detected in membrane-compartmentalized organelles, but the functional significance has remained elusive. Here, we report that miR-1, a microRNA specifically induced during myogenesis, efficiently enters the mitochondria where it unexpectedly stimulates, rather than represses, the translation of specific mitochondrial genome-encoded transcripts. We show that this positive effect requires specific miR:mRNA base-pairing and Ago2, but not its functional partner GW182, which is excluded from the mitochondria. We provide evidence for the direct action of Ago2 in mitochondrial translation by crosslinking immunoprecipitation coupled with deep sequencing (CLIP-seq), functional rescue with mitochondria-targeted Ago2, and selective inhibition of the microRNA machinery in the cytoplasm. These findings unveil a positive function of microRNA in mitochondrial translation and suggest a highly coordinated myogenic program via miR-1-mediated translational stimulation in the mitochondria and repression in the cytoplasm.
LinkOut: [PMID: 25083871]
|
CLIP-seq Support 1 for dataset GSM1385342 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | C2C12 / C2C12_GM_Ago2_CLIP-Seq_myoblast |
Location of target site | NM_026165 | 3UTR | UUGUAUGUGUGCGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUAUGUAAAGUUUUAUUCUCCAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 25083871 / GSE57596 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1385343 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | C2C12 / C2C12_DM_Ago2_CLIP-Seq_myotubes |
Location of target site | NM_026165 | 3UTR | UUUUUGUAUGUGUGCGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUGUAUGUAAAGUUUUAUUCUCCAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 25083871 / GSE57596 |
CLIP-seq Viewer | Link |
14 mmu-miR-3057-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT580946 | Slc25a46 | solute carrier family 25, member 46 | 2 | 2 | ||||||||
MIRT581084 | Serpinb5 | serine (or cysteine) peptidase inhibitor, clade B, member 5 | 2 | 2 | ||||||||
MIRT584738 | Atp2b2 | ATPase, Ca++ transporting, plasma membrane 2 | 2 | 2 | ||||||||
MIRT591856 | Iffo2 | intermediate filament family orphan 2 | 2 | 2 | ||||||||
MIRT593687 | Sco1 | SCO1 cytochrome c oxidase assembly protein | 2 | 2 | ||||||||
MIRT593742 | Pld5 | phospholipase D family, member 5 | 2 | 2 | ||||||||
MIRT593830 | Klhl31 | kelch-like 31 | 2 | 2 | ||||||||
MIRT593961 | Col4a1 | collagen, type IV, alpha 1 | 2 | 2 | ||||||||
MIRT594311 | Nr3c1 | nuclear receptor subfamily 3, group C, member 1 | 2 | 2 | ||||||||
MIRT595177 | Zfp953 | zinc finger protein 953 | 2 | 2 | ||||||||
MIRT598903 | Gla | galactosidase, alpha | 2 | 2 | ||||||||
MIRT603414 | Samd7 | sterile alpha motif domain containing 7 | 2 | 2 | ||||||||
MIRT603667 | Opa3 | optic atrophy 3 | 2 | 2 | ||||||||
MIRT606751 | Tns4 | tensin 4 | 2 | 2 |